Literature DB >> 2379999

Relationship of plasma and urine composition to recurrence of calcium urinary stones in patients on drug therapy.

K Kohri1, T Umekawa, Y Ishikawa, Y Katayama, M Kodama, M Takada, Y Katoh, K Kataoka, M Iguchi, T Kurita.   

Abstract

Factors relating alterations in plasma and urine composition to recurrence of urinary stones during drug therapy were investigated by using a multiple regression analysis technique. These factors were influenced not only by the efficacy of the drugs but also by other factors (plasma or urinary constituents and overall health of the patients, etc.). In order to study the effect of drug therapy or other treatment on the alteration of plasma and urine constituents, multiple regression analysis is more appropriate than Student's paired t-test which has been used by some workers. These two analytical methods yield different results even if used on the same data.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2379999     DOI: 10.1007/bf02550431

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  9 in total

1.  Placebo versus allopurinol for renal calculi.

Authors:  M J Smith
Journal:  J Urol       Date:  1977-06       Impact factor: 7.450

2.  Effect of long-term thiazide therapy on intestinal calcium absorption in patients with recurrent renal calculi.

Authors:  U Ehrig; J E Harrison; D R Wilson
Journal:  Metabolism       Date:  1974-02       Impact factor: 8.694

3.  [A study of allopurinol in the prevention of recurrent calcium oxalate stones].

Authors:  T Sonoda; T Koide; T Oka; H Sakaguchi; H Itatani; T Ohkawa; S Ebisuno; S Morimoto; O Yoshida; Y Okada
Journal:  Hinyokika Kiyo       Date:  1985-11

4.  Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones.

Authors:  J T Mortensen; A Schultz; A H Ostergaard
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

5.  Randomized trial of allopurinol in the prevention of calcium oxalate calculi.

Authors:  B Ettinger; A Tang; J T Citron; B Livermore; T Williams
Journal:  N Engl J Med       Date:  1986-11-27       Impact factor: 91.245

6.  Allopurinol treatment of renal calcium stone disease.

Authors:  B Fellström; U Backman; B G Danielson; K Holmgren; G Johansson; M Lindsjö; S Ljunghall; B Wikström
Journal:  Br J Urol       Date:  1985-08

7.  Parathyroid hormone and electrolytes during long-term treatment with allopurinol and thiazide.

Authors:  K Kohri; M Takada; Y Katoh; K Kataoka; M Iguchi; S Yachiku; T Kurita
Journal:  Br J Urol       Date:  1987-06

8.  Change in inhibitory potential in urine of hyperuricosuric calcium oxalate stone formers effected by allopurinol and orthophosphates.

Authors:  B Goldwasser; S Sarig; R Azoury; Y Wax; D Hirsch; S Perlberg; M Many
Journal:  J Urol       Date:  1984-11       Impact factor: 7.450

9.  Clinical experience with long-term bendroflumethiazide treatment in calcium oxalate stone formers.

Authors:  C Ahlstrand; H G Tiselius; L Larsson; E Hellgren
Journal:  Br J Urol       Date:  1984-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.